|
|
|
Insider
Information: |
Clarke C Boyd |
Relationship: |
Former Director |
City: |
Horsham |
State: |
PA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
158,431 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$407,168 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
158,431 |
|
|
Total
Value |
$407,168 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neose Technologies Inc |
NTEC |
Director |
2006-09-07 |
158,431 |
2004-05-17 |
0 |
Premium* |
|
Novelion Therapeutics Inc |
NVLN |
Former Director |
2012-07-09 |
0 |
2012-07-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NTEC |
Neose Technologies Inc |
President & CEO |
|
2004-05-17 |
4 |
B |
$6.77 |
$354,998 |
D/D |
52,437 |
87,637 |
2.81 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Director |
|
2004-11-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,000 |
|
- |
|
NTEC |
Neose Technologies Inc |
President and CEO |
|
2005-05-05 |
4 |
B |
$2.68 |
$27,365 |
D/D |
10,000 |
97,637 |
2.81 |
- |
|
NTEC |
Neose Technologies Inc |
Director |
|
2006-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
81,058 |
178,695 |
|
- |
|
NTEC |
Neose Technologies Inc |
Director |
|
2006-09-07 |
4 |
D |
$2.78 |
$56,334 |
D/D |
(20,264) |
158,431 |
|
- |
|
NVLN |
Novelion Therapeutics Inc |
Director |
|
2007-05-07 |
4 |
B |
$7.38 |
$73,800 |
D/D |
10,000 |
13,000 |
2.39 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Director |
|
2007-10-26 |
4 |
B |
$4.45 |
$62,860 |
D/D |
14,000 |
27,000 |
2.39 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Director |
|
2008-10-30 |
4 |
B |
$2.44 |
$24,594 |
D/D |
10,000 |
37,000 |
2.39 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Director |
|
2009-02-23 |
4 |
B |
$1.72 |
$6,879 |
D/D |
4,000 |
41,000 |
2.39 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Director |
|
2009-03-04 |
4 |
B |
$1.61 |
$16,069 |
D/D |
10,000 |
51,000 |
2.39 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Director |
|
2009-05-12 |
4 |
B |
$2.21 |
$22,100 |
D/D |
10,000 |
61,000 |
2.39 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Director |
|
2009-11-03 |
4 |
B |
$3.38 |
$16,944 |
D/D |
5,000 |
66,000 |
2.39 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Director |
|
2010-08-02 |
4 |
B |
$5.75 |
$17,248 |
D/D |
3,000 |
69,000 |
2.39 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Director |
|
2011-06-17 |
4 |
B |
$6.75 |
$27,000 |
D/D |
4,000 |
73,000 |
2.39 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Director |
|
2012-05-15 |
4 |
B |
$6.56 |
$16,072 |
D/D |
2,450 |
75,450 |
2.39 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Former Director |
|
2012-06-06 |
4/A |
GA |
$0.00 |
$0 |
I/I |
20,000 |
20,000 |
0 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Former Director |
|
2012-06-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
55,450 |
0 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Former Director |
|
2012-07-09 |
4 |
S |
$7.62 |
$152,460 |
I/I |
(20,000) |
0 |
0 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Former Director |
|
2012-07-09 |
4 |
S |
$7.62 |
$422,291 |
D/D |
(55,450) |
0 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|